Overview Financials News + Filings Key Docs Charts Ownership Insiders |
ASCENT INDUSTRIES CO. (SYNL)
|
Add to portfolio |
|
|
Price: |
$9.48
| | Metrics |
OS: |
10.2
|
M
| |
-17
|
% ROE
|
Market cap: |
$96.3
|
M
| |
-3
|
% ROIC
|
Net debt:
|
$53.8
|
M
| |
|
|
EV:
|
$150
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($2.4)
|
M
| |
|
|
EBIT
|
($13.5)
|
M
| |
|
|
EPS |
($0.81)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 414.1 | 334.7 | 256.0 | 305.2 | 280.8 | 201.1 | 138.6 | 175.5 |
Revenue growth | 23.7% | 30.7% | -16.1% | 8.7% | 39.6% | 45.2% | -21.0% | -12.1% |
Cost of goods sold | 357.6 | 273.9 | 233.3 | 274.4 | 229.6 | 173.1 | 121.7 | 150.1 |
Gross profit | 56.5 | 60.8 | 22.7 | 30.8 | 51.2 | 28.1 | 16.9 | 25.3 |
Gross margin | 13.7% | 18.2% | 8.8% | 10.1% | 18.2% | 14.0% | 12.2% | 14.4% |
Selling, general and administrative | 35.0 | 30.1 | 28.7 | 32.6 | 27.7 | 24.9 | 22.7 | 21.9 |
EBITA | 25.6 | 33.2 | -6.0 | 1.6 | 26.3 | 5.9 | -5.7 | 5.6 |
EBITA margin | 6.2% | 9.9% | -2.3% | 0.5% | 9.4% | 3.0% | -4.1% | 3.2% |
Amortization of intangibles | 4.0 | 2.8 | 3.0 | 3.5 | 2.4 | 2.4 | 2.5 | 2.3 |
EBIT | 21.6 | 30.5 | -9.0 | -1.9 | 23.9 | 3.5 | -8.1 | 3.4 |
EBIT margin | 5.2% | 9.1% | -3.5% | -0.6% | 8.5% | 1.8% | -5.9% | 1.9% |
Pre-tax income | 17.9 | 25.5 | -32.0 | -3.8 | 16.5 | 1.5 | -9.2 | -8.5 |
Income taxes | -4.2 | 5.3 | -4.7 | -0.7 | 3.4 | 0.1 | -2.2 | 1.8 |
Tax rate | | 20.6% | 14.7% | 19.3% | 20.5% | 9.3% | 23.9% | |
Net income | 22.1 | 20.2 | -27.3 | -3.0 | 13.1 | 1.3 | -7.1 | -11.5 |
Net margin | 5.3% | 6.0% | -10.7% | -1.0% | 4.7% | 0.7% | -5.1% | -6.6% |
|
Diluted EPS | $2.12 | $2.14 | ($2.98) | ($0.34) | $1.48 | $0.15 | ($0.81) | ($1.18) |
Shares outstanding (diluted) | 10.4 | 9.5 | 9.1 | 9.0 | 8.9 | 8.7 | 8.6 | 8.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|